Menu ×


Drug Delivery Devices Market Segmentation by Device Type (Smart Pills, Inhalers, Drug Eluting Stents, Safety Syringes, Implantable Drug Delivery Device, Transdermal Patches, and Others); by Route of Administration (Oral, Transdermal, Injectable, and Others); and by Distribution Channel (Hospital, Pharmacies, Surgical Centers, and Others) – Global Demand Analysis & Opportunity Outlook 2031

  • Text Size:

Inflation And Looming Recession to Haunt Businesses:

In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.

Request Insights

Purchasing power in the couPurchasing power in the country is expected to fell nearly by 2.5%. On the other hand, European countries to see the worst coming in the form of energy crisis especially in upcoming winters!! Right after COVID-19, inflation has started gripping the economies across the globe. Higher than anticipated inflation, especially in western world had raised concerns for national banks and financial institutions to control the economic loss and safeguard the interest of the businesses. Increased interest rates, strong USD inflated oil prices, looming prices for gas and energy resources due to Ukraine-Russia conflict, China economic slowdown (~4% in 2022) disrupting the production and global supply chain and other factors would impact each industry negatively.                                                         Request Insights

Read More


  • July, 2021: Janssen Pharmaceutical Inc., a subsidiary company of Johnson & Johnson announced the FDA approval of drug Darzalex Faspro for treatment of Multiple Myeloma Cancer.

  • June, 2020: IDEAYA Biosciences, Inc. and GlaxoSmithKline plc. (GSK) announced a strategic partnership to develop solutions in the field of Oncology. 

Global Drug Delivery Devices Market Highlights over 2022 – 2031

The global drug delivery devices market is estimated to grow at a CAGR of ~5.5% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the rising need for targeted drug delivery, backed by the increasing prevalence of cancer and genetic diseases. According to the data by the World Health Organization (WHO), nearly 10 million deaths were caused by cancer in 2020. Cancer requires specifically targeted drugs for the cancerous cells, which is why, it is estimated to boost the market growth. Drug delivery devices control the rate of drug release and the location in the body where it is released.

Drug Delivery Devices Market

Moreover, the increasing global expenditure in the healthcare sector, along with rising health awareness is estimated to boost the market growth. As per the statistics by the World Bank, 9.856% of the global GDP was spent on healthcare, in 2018. Along with this, people prefer early treatment of cancer, backed by the increased disposable income and medical reimbursement policies, which is estimated to propel the market growth. Additionally, rising cases of different types of cancer, along with increasing cancer mortality rate, are expected to fuel the market growth. According to the WHO data, 1.80 million were caused by lung cancer, 935 000 deaths were caused by colon-rectum cancer, and 685 000 deaths were caused by breast cancer in 2020 itself.   

Most Common Causes of Cancer Deaths (Number of Deaths), World, 2020

The market is segmented by device type into smart pills, inhalers, drug eluting stents, safety syringes, implantable drug delivery device, transdermal patches, and others. Out of these, the smart pills segment is anticipated to hold the notable share in the global drug delivery devices market over the forecast period on account of various advantages of smart pills, such as, sensing, imaging, and drug delivery. CLICK TO DOWNLOAD SAMPLE REPORT

Major Macro-Economic Indicators Impacting the Market Growth

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years. 

Global Drug Delivery Devices Market Regional Synopsis

On the basis of geographical analysis, the global drug delivery devices market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in Asia Pacific region is estimated to witness noteworthy growth over the forecast period on the back of increasing prevalence of cancer in the region, along with increasing healthcare awareness amongst the people.

The market in the North America region is anticipated to gain the largest market share throughout the forecast period owing to the high prevalence of cancer in the region. According to the National Cancer Institute, an estimated 1,806,590 new cases of cancer were diagnosed in the United States in 2020.

Drug Delivery Devices Market Share

The global drug delivery devices market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth, Market Players Analysis & Opportunity Outlook

Market Segmentation

Our in-depth analysis of the global drug delivery devices market includes the following segments:

By Device Type

  • Smart Pills
  • Inhalers
  • Drug Eluting Stents
  • Safety Syringes
  • Implantable Drug Delivery Device
  • Transdermal Patches
  • Others

By Route of Administration

  • Oral
  • Transdermal
  • Injectable
  • Others

By Distribution Channel

  • Hospital
  • Pharmacies
  • Surgical Centers
  • Others

Growth Drivers

  • Growing Need for Targeted Drug Delivery
  • Increasing Prevalence of Cancer


  • Risk of Needle Stick Injuries
  • Increasing Use of Generic Drugs

Top Featured Companies Dominating the Market

  • Antares Pharma, Inc.
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis 
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Novartis International AG
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.,
  • Abbott Laboratories
  • Cipla Limited


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved